Based on KFF analysis of Medicare data from 2020, an estimated 7% of Medicare beneficiaries, or 3.6 million overall, had established cardiovascular disease and obesity or overweight in 2020, and so could be eligible for Medicare coverage of Wegovy for its new indication (Figure 1) (see Methods for details)
10.2174/138920006778520561 Curr Drug Metab
"GLP-1 medications can be life-changing for some people," she offered
Food and Drug Administration to treat type 2 diabetes and other metabolic conditions, those prescribed the medications were often told to expect to take the drug for life
However, the weight loss caused by GLP-1s can also lead to muscle loss if steps arent taken to protect muscle health
Innovative Products: Danone invests on products like Oikos Fusion, a first-of-its-kind cultured dairy drink, supports GLP-1 consumers by preserving muscle while meeting weight loss goals